PIAS3 and squamous cell lung carcinoma: This necessitates the discovery of other small molecule activators of PIAS3 expression, perhaps a preexisting therapeutic agent, if we hope to achieve our goal of PIAS3-targeted therapy in squamous cell lung cancer.